| Catalog | name | Description | price |
|---|---|---|---|
| R-M-1097 | PAR-2 (6-1) amide (human) trifluoroacetate salt,CAS: 942413-05-0 | CAS: 942413-05-0,PAR-2 (6-1) amide (human) trifluoroacetate salt from ruixi.Retro-sequence of the proteinase-activated receptor-2 (PAR-2). VKGILS-amide is commonly used as an inactive control. | price> |
| R-M-1098 | PAR-2 (1-6) amide (human) (scrambled) trifluoroacetate salt,CAS:1348395-60-7 | LSIGKV-amide, a partially reversed human PAR-2 activating peptide serving as an inactive control for the PAR-2 agonist SLIGKV-amide. | price> |
| R-M-1099 | PAR-2 (1-6) amide (mouse, rat) trifluoroacetate salt,CAS:171436-38-7 | SLIGRL-amide, protease-activated receptor-2 (PAR2) selective agonist. The reverted PAR2 peptide can be used as inactive control. | price> |
| R-M-1100 | PAR-2 (1-6) (mouse, rat) trifluoroacetate salt,CAS : 164081-25-8 | Tethered ligand sequence of mouse PAR-2, which like the thrombin receptor is a protease-activated receptor present in keratinocytes. SLIGRL was found to be equipotent with SFLLRN in activating keratinocyte inositolphospholipid hydrolysis and calcium mobilization. | price> |
| R-M-1101 | (2-Furoyl)-PAR-2 (2-6)-Orn amide (mouse, rat) trifluoroacetate salt,CAS:729589-58-6 | (2-Furoyl)-PAR-2 (2-6)-Orn amide (mouse, rat) is a potent and selective PAR-2 agonist. In cultured human PAR-2-expressing cells (2-Furoyl)-LIGRLO-amide was equally effective as SLIGRL-amide, in rat PAR-2-expressing cells it was 10 to 25 times more potent than SLIGRLamide in increasing intracellular calcium levels. In bioassays of tissue PAR-2 activity, measured as arterial vasodilation and hyperpolarization this agonist was 10 to 300 times more potent than SLIGRLamide. | price> |
| R-M-1102 | PAR-2 (6-1) amide (mouse, rat) trifluoroacetate salt,CAS: 245329-01-5 | PAR-2 (6-1) amide (mouse, rat) trifluoroacetate salt,CAS: 245329-01-5 from ruixi.It is a synthetic peptide and can be used in the research of Hematology. | price> |
| R-M-1103 | PAR-3 (1-6) (human) trifluoroacetate salt,CAS:320347-28-2 | The sequence TFRGAP mimicks the putative tethered ligand of human PAR-3 (protease activated receptor 3). | price> |
| R-M-1108 | Peptide Lv (rat) trifluoroacetate salt,CAS:1872441-58-1 | Peptide Lv has been discovered via a computational bioinformatics-based screening process. The neuropeptide is expressed in retinal photoreceptor layer, hippocampus, olfactory bulb, cerebellum, cerebral cortex, lung, spleen, liver and intestine. Peptide Lv enhances L-type voltage-gated calcium channel (L-VGCC) currents in retinal photoreceptors. | price> |
| R-M-1110 | Peptide WE-14,CAS:115136-18-0 | WE-14, a chromogranin A-derived peptide, was isolated from a human ileal carcinoid tumor. Its sequence WSKMDQLAKELTAE is highly conserved in many mammalian species and flanked by typical processing sites. Such factors would indicate a potential physiological role for peptide WE-14. | price> |
| R-M-1112 | Peptide YY (3-36) (canine, mouse, porcine, rat) trifluoroacetate salt,CAS:126339-09-1 | Peptide YY (3-36) and peptide YY are both synthesized by the gastrointestinal tract and released into the circulation after a meal. Peptide YY (3-36) is a Y₂ receptor subtype agonist, whereas peptide YY is non-selective for Y₁ and Y₂ receptor subtypes. It has been suggested that Y₁ and Y₂ receptor subtype binding affinities depend on their secondary and tertiary solution state structures. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


